CDKN2A and cancer: We evaluated at eight cancer types with high frequencies of CDKN2A VAR and a significant influence on patient outcomes: ESCA (Esophageal carcinoma), KIRC (Kidney renal clear cell carcinoma), KIRP (Kidney renal papillary cell carcinoma), LUAD (Lung adenocarcinoma), MESO (Mesothelioma), pancreatic (PAAD), SARC (Sarcoma) and Stomach adenocarcinoma (STAD).